Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Peripheral Nerve-Derived Stem Cell Spheroids Induce Functional Recovery and Repair after Spinal Cord Injury in Rodents

Peripheral Nerve-Derived Stem Cell Spheroids Induce Functional Recovery and Repair after Spinal Cord Injury in Rodents

International Journal of Molecular Sciences, 2021 · DOI: 10.3390/ijms22084141 · Published: April 16, 2021

Spinal Cord InjuryRegenerative Medicine

Simple Explanation

This study investigates the potential of peripheral nerve-derived stem cells (PNSCs) in treating spinal cord injury (SCI). PNSCs, isolated from adult peripheral nerves, possess characteristics similar to neural crest stem cells, showing the ability to differentiate into various cell types like Schwann cells and neurons. The research highlights that PNSCs can be enhanced by developing them into spheroids, which secrete more neurotrophic factors and express extracellular matrix. These spheroids have shown promising results in animal SCI models, inducing functional recovery and neuronal regeneration. The findings suggest that these PNSC spheroids could be a new therapeutic approach for SCI patients. They not only promote functional recovery but also reduce neuropathic pain associated with SCI after remyelination.

Study Duration
8 Weeks
Participants
SD rats (200 ± 20 g)
Evidence Level
Not specified

Key Findings

  • 1
    PNSC spheroids significantly improved functional recovery in a rodent SCI model, as indicated by increased BBB scores compared to single-cell PNSCs and the SCI/PBS group.
  • 2
    The study found that PNSC spheroids reduced mechanical allodynia and inflammation following SCI, evidenced by improved scores on the dynamic plantar test and reduced IL-1β expression.
  • 3
    Transplanted PNSCs, particularly in spheroid form, induced increased expression of neurotrophic factors such as NT-3, which contributed to neuroprotection and neuronal regeneration.

Research Summary

The study successfully isolated PNSCs from adult peripheral nerves, demonstrating their multipotent differentiation potential into various cell types and their ability to secrete neurotrophic factors. PNSC spheroids exhibited enhanced therapeutic potential compared to single-cell PNSCs, showing increased secretion of neurotrophic factors and improved functional recovery in a rodent SCI model. The findings suggest that PNSC spheroids can improve both motor function and neuropathic pain after SCI, indicating their potential as a new clinical treatment for managing SCI.

Practical Implications

Therapeutic Development

PNSC spheroids represent a promising cell-based therapy for spinal cord injury, potentially overcoming limitations of existing treatments.

Clinical Translation

The ease of obtaining adult peripheral nerves for isolating PNSCs makes this approach more clinically feasible than using fetal tissue-derived neural stem cells.

Pain Management

PNSC spheroids can mitigate neuropathic pain, a common complication in SCI patients, by reducing inflammation and promoting remyelination.

Study Limitations

  • 1
    The transplanted PNSCs did not survive long-term (beyond three weeks), suggesting that the therapeutic effects are primarily due to paracrine signaling.
  • 2
    While the PNSCs showed substantial differentiation potential in vitro, cell differentiation and engraftment were not observed in vivo.
  • 3
    Further research is needed to fully elucidate the mechanisms of action and optimize the therapeutic efficacy of PNSC spheroids for SCI treatment.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury